X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ACTA PHARMACOLOGICA SINICA

期刊標題檢索 ACTA PHARMACOL 最新評論: Will it remain under review after this? (2024-05-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ACTA PHARMACOLOGICA SINICA]您好,您是該頁面的第 161724 位訪客。

期刊簡介
期刊名稱ACTA PHARMACOLOGICA SINICA ACTA PHARMACOLOGICA SINICA
LetPub Score
8.6
52 ratings
Rate

Reputation
9.7

Influence
7.7

Speed
9.5

期刊簡稱ACTA PHARMACOL SIN
ISSN1671-4083
E-ISSN1745-7254
h-index78
CiteScore
CiteScoreSJRSNIPCiteScore Rank
15.101.8821.380
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q18 / 272
Category: Medicine
Subcategory: Pharmacology
Q115 / 313

自引率 (2023-2024)1.40%自引率趨勢
掲載範囲
APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.
官方網站https://www.nature.com/aps
在線稿件提交https://mc.manuscriptcentral.com/aphs
開放訪問No
出版商Nature Publishing Group
主題領域医学
出版國/地區PEOPLES R CHINA
發行頻率月刊
創刊年1980
每年文章數156每年文章數趨勢
黃金OA百分比11.43%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MULTIDISCIPLINARYSCIEQ147/230
PHARMACOLOGY & PHARMACYSCIEQ115/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1671-4083%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 63.75%
參考鏈接
相關期刊 【ACTA PHARMACOLOGICA SINICA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CHEMICAL REVIEWSH-index: 609

    CiteScore: 106.00
    CHEMICAL SOCIETY REVIEWSH-index: 432

    CiteScore: 80.80
    Nature ChemistryH-index: 187

    CiteScore: 29.60
    ACCOUNTS OF CHEMICAL RESEARCHH-index: 354

    CiteScore: 31.40
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITIONH-index: 482

    CiteScore: 26.60
    Journal of the American Chemical SocietyH-index: 542

    CiteScore: 24.40
    JOURNAL OF CONTROLLED RELEASEH-index: 237

    CiteScore: 18.50
    CHINESE CHEMICAL LETTERSH-index: 41

    CiteScore: 14.10
    GREEN CHEMISTRYH-index: 186

    CiteScore: 16.10
    ULTRASONICS SONOCHEMISTRYH-index: 109

    CiteScore: 15.80
    學科內最受檢索的期刊 頁面查看次數
    CHEMICAL COMMUNICATIONS1241605
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES1241414
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION1079781
    Journal of the American Chemical Society839543
    NEW JOURNAL OF CHEMISTRY664941
    GREEN CHEMISTRY663381
    CHEMISTRY-A EUROPEAN JOURNAL500511
    CHINESE CHEMICAL LETTERS496262
    ChemSusChem467816
    CRYSTENGCOMM369303
  •  

    ACTA PHARMACOLOGICA SINICA ACTA PHARMACOLOGICA SINICA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)
  [ACTA PHARMACOLOGICA SINICA] 的評論撰寫評論
作者: Brady Valentine


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-21 15:04:37 評論於
Will it remain under review after this?
(0) 讚! | Brady Valentine

作者: 弗雷达以西结


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-26 12:32:59 評論於
Hello, may I ask when will the editor be assigned?
(0) 讚! | 弗雷达以西结

作者: Dunn Catharine


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 09:06:42 評論於
Research focus: Circadian clock; Pharmacology experience sharing: Currently preparing for submission, seeking advice on two questions, 1. Does APS require uncut original WB images? 2. Is it necessary to upload mass spectrometry data?
(0) 讚! | Dunn Catharine

作者: 平原从安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-16 13:20:08 評論於
Boss, I also resubmitted my rejected manuscript, but why has it been stuck at "Awaiting Reviewer Assignment" for a week now? Is your re-submission in the same state?
(0) 讚! | 平原从安

作者: 窅恒少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-14 20:35:32 評論於
Review speed: 1.0 | Submission hit rate: 75.0 Emphasis on research direction: Leukemia experience sharing: Just accepted recently, here to share some experience. I am conducting research on the combination therapy mechanism of leukemia. Overall, my innovation points are not sufficient but the experiments are solid. Submitted on April 17 and received comments on May 16: Reject and resubmit, but the system is open for revisions with a two-month revision period, later automatically extended to three months. The reviewer comments are acceptable as well. I checked online at that time and found that this journal is aiming to shorten the online submission time, so major revisions mean rejection and resubmission. Revised on August 8, received comments on September 5, need major revisions, but only one reviewer has comments, and additional data is needed. Revised on September 21 and accepted in principle on October 15. I was worried about the WB original issue at that time, but the editor did not ask for it. When I first submitted, there were two "awaiting editor recommendation" statuses, likely because one of the two initial reviewers had negative comments, and the editor thought the quality of the article was alright and then found another reviewer, who gave positive feedback. The editor was nice throughout the process
(0) 讚! | 窅恒少爷

作者: 窅恒少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-14 08:09:51 評論於
Please translate the following paragraph into English and Japanese, and title them ":" and ":"
(0) 讚! | 窅恒少爷

作者: 窅恒少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-13 21:20:59 評論於
Review speed: 1.0 | Submission hit rate: 75.0 Emphasis on research direction: leukemia Experience sharing: Just recently received a joint treatment mechanism study on leukemia. The main drugs used are Chinese herbal ingredients. Submitted on 4.17, received review comments on 5.16, rejected and resubmitted, but was given access to the revision system, with a little over two months given. The review comments are acceptable, but there are still quite a few experiments to be done. Upon researching online, it seems that the journal may reject resubmissions for major revisions in order to shorten the review time online. This does not count as part of the overall review time. Revised on 8.8, received second review comments on 9.5, major revisions were requested with two months given, but both reviewers had no comments, only the first one had some experiments to add. Revised on 9.21, received third review comments on 10.15, minor revisions were requested within a month, which were only regarding formatting. Upon revising, I received an email of conditional acceptance on the same day. My article has a lot of western blot data, but the journal did not request original figures
(0) 讚! | 窅恒少爷

作者: 平原从安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 14:19:40 評論於
Hey, could you please ask if the status after rejecting and resubmitting is the same as before? Is it "Awaiting Reviewer Assignment" and then "Awaiting Reviewer Scores" again? Thank you
(0) 讚! | 平原从安

作者: 两仪景胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 13:04:49 評論於
No revisions were made, and the paper was accepted as is by the original reviewer
(0) 讚! | 两仪景胜

作者: 平原从安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-08 22:34:31 評論於
Excuse me, I wanted to ask you about the status of Acta Pharmacol Sin after you rejected and resubmitted it. It is currently Under review-Awaiting Reviewer Assignment
(0) 讚! | 平原从安

作者: 平原从安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-07 21:00:25 評論於
I did too, but I resubmitted and added two new reviewers. Did you not add any additional reviewers?
(0) 讚! | 平原从安

作者: 北海和平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 19:39:33 評論於
Do you need me to provide it? Just asking
(0) 讚! | 北海和平

作者: 黄土又蓉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-09 21:34:36 評論於
Have you also received our articles?
(0) 讚! | 黄土又蓉

作者: 两仪景胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 23:46:05 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0 
Research focus: pancreatic cancer 
Experience sharing: Recently received a basic research paper and would like to share our experience. There are certain requirements for the workload and innovation of the article. After being rejected and resubmitted for the first time, we carefully revised the feedback and it was accepted. It was the first time for our article to be accepted in a top-tier journal. Grateful for the opportunity
(0) 讚! | 两仪景胜

作者: Guy Christy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-26 15:14:56 評論於
Under review means the editor is reviewing it; awaiting reviewer assignment means it has been sent for external review, please be patient~ Wish you good luck!
(0) 讚! | Guy Christy

作者: 两仪景胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-25 19:34:05 評論於
As of August 2023, we have not yet surpassed the 10-point mark
(0) 讚! | 两仪景胜

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-03 22:03:12 評論於
How long does it usually take for senior recommendation after this revision awaiting editor?
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-03 16:27:21 評論於
How long does it usually take for senior colleagues to receive editor recommendations after revisions?
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-03 13:43:21 評論於
Hello, how long does the second review generally take?
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 23:13:36 評論於
How long does it usually take for the second review, senior?
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 17:17:00 評論於
Senior, what's going on? Did you finally accept it?
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 15:00:52 評論於
Senior, what is going on? Have you finally accepted it?
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 13:13:31 評論於
Senior, what's going on with you? I am experiencing the same situation
(0) 讚! | 吐纳听双

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 13:04:18 評論於
Senior, what's going on? Did you finally accept it?
(0) 讚! | 吐纳听双

作者: 东海宇泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-29 20:10:21 評論於
Is this because there are more reviewers?
(0) 讚! | 东海宇泽

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)

開始撰寫 [ACTA PHARMACOLOGICA SINICA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*